FDA NDC Directory · JSON-LD · Markdown

Guaifenesin and Pseudoephedrine HCl

NDC 0363-0134 · HUMAN OTC DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerWALGREEN CO.
Marketing categoryAbbreviated NDA (generic) · App ANDA213203
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsGUAIFENESIN (1200 mg/1)
PSEUDOEPHEDRINE HYDROCHLORIDE (120 mg/1)
Marketing started20200805
Package count1

External sources

Source: openFDA. Public-domain (CC0).